Wilms tumor
ICD-10 C64.1 · ICD-11 2C90.Y&XH5QN3

Treatment of Wilms Tumor in Children with Hemihyperplasia or Beckwith-Wiedemann Syndrome

This protocol covers the first-line management of favorable histology Wilms tumor presenting as a localized, unilateral renal mass in children who carry a genetic predisposing condition — specifically hemihyperplasia or Beckwith-Wiedemann syndrome.

Clinical scenario

A child with a localized unilateral kidney tumor of favorable histology in the setting of a predisposing genetic condition — hemihyperplasia or Beckwith-Wiedemann syndrome. The presence of a predisposing condition is a key factor that shapes the initial management approach.

Treatment approach

The standard strategy begins with neoadjuvant chemotherapy before definitive surgery. The specific regimen used depends on whether an upfront biopsy was performed prior to starting treatment.

The full regimen options, timing, surgical decision criteria, lymph node sampling requirements, and response-adapted algorithm are detailed in the structured protocol.

Treatment goals

The primary clinical goal is to achieve a complete or partial tumor response at week 6, making the tumor resectable — and enabling nephron-sparing surgery where achievable.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.6004/jnccn.2021.0037

View source ↗